Rockefeller Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$243K Buy
67,826
+3,604
+6% +$14.3K ﹤0.01% 2378
2025
Q4
$225K Sell
64,222
-42,760
-40% -$146K ﹤0.01% 2305
2025
Q3
$349K Buy
106,982
+10,000
+10% +$31.5K ﹤0.01% 1946
2025
Q2
$238K Buy
96,982
+6,580
+7% +$33.3K ﹤0.01% 1689
2025
Q1
$603K Buy
90,402
+1,837
+2% +$18.1K ﹤0.01% 1427
2024
Q4
$1.11M Sell
88,565
-19,347
-18% -$291K ﹤0.01% 1212
2024
Q3
$1.99M Buy
107,912
+20,939
+24% +$429K 0.01% 995
2024
Q2
$1.87M Buy
86,973
+1,511
+2% +$34.7K 0.01% 1000
2024
Q1
$2.3M Sell
85,462
-2
-0% -$57 0.01% 949
2023
Q4
$2.56M Sell
85,464
-6,400
-7% -$141K 0.01% 832
2023
Q3
$1.88M Buy
91,864
+9,750
+12% +$177K 0.01% 870
2023
Q2
$1.63M Buy
82,114
+14,000
+21% +$283K 0.01% 915
2023
Q1
$1.17M Buy
68,114
+21,000
+45% +$411K 0.01% 1011
2022
Q4
$921K Buy
47,114
+5,000
+12% +$92.1K ﹤0.01% 1037
2022
Q3
$671K Buy
42,114
+3,074
+8% +$48K ﹤0.01% 1156
2022
Q2
$537K Buy
39,040
+38
+0.1% +$453 ﹤0.01% 1233
2022
Q1
$618K Buy
39,002
+600
+2% +$10.4K ﹤0.01% 1238
2021
Q4
$838K Buy
38,402
+25,200
+191% +$687K ﹤0.01% 1111
2021
Q3
$394K Buy
+13,202
New +$481K ﹤0.01% 1344
2021
Q2
Sell
-2,330
Closed -$103K 3574
2021
Q1
$103K Hold
2,330
﹤0.01% 1584
2020
Q4
$127K Buy
+2,330
New +$84.9K ﹤0.01% 1350
2020
Q3
Sell
-4,743
Closed -$99K 2755
2020
Q2
$99K Hold
4,743
﹤0.01% 1168
2020
Q1
$66K Sell
4,743
-1,538
-24% -$30.5K ﹤0.01% 1154
2019
Q4
$143K Sell
6,281
-80
-1% -$1.34K ﹤0.01% 857
2019
Q3
$74K Sell
6,361
-248
-4% -$3.08K ﹤0.01% 869
2019
Q2
$100K Hold
6,609
﹤0.01% 691
2019
Q1
$116K Buy
6,609
+500
+8% +$7.89K ﹤0.01% 722
2018
Q4
$91K Hold
6,109
﹤0.01% 468
2018
Q3
$150K Buy
+6,109
New +$133K ﹤0.01% 371

Other funds holding RCKT